These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31785827)

  • 41. Good governance and corruption in the health sector: lessons from the Karnataka experience.
    Huss R; Green A; Sudarshan H; Karpagam S; Ramani K; Tomson G; Gerein N
    Health Policy Plan; 2011 Nov; 26(6):471-84. PubMed ID: 21169338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preventing corruption in humanitarian assistance: perceptions, gaps and challenges.
    Maxwell D; Bailey S; Harvey P; Walker P; Sharbatke-Church C; Savage K
    Disasters; 2012 Jan; 36(1):140-60. PubMed ID: 21623891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk.
    Kohler JC; Dimancesco D
    Glob Health Action; 2020; 13(sup1):1694745. PubMed ID: 32194011
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of data audits in detecting scientific misconduct. Results of the FDA program.
    Shapiro MF; Charrow RP
    JAMA; 1989 May; 261(17):2505-11. PubMed ID: 2704109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Responding to scientific misconduct. Due process and prevention.
    Mishkin B
    JAMA; 1988 Oct; 260(13):1932-6. PubMed ID: 3418855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bhisho corruption-busting now the national pilot.
    Bateman C
    S Afr Med J; 2012 Apr; 102(5):274-6. PubMed ID: 22554327
    [No Abstract]   [Full Text] [Related]  

  • 47. AIDS NGOS and corruption in Nigeria.
    Smith DJ
    Health Place; 2012 May; 18(3):475-80. PubMed ID: 22469532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Corruption practices in drug prescribing in Vietnam - an analysis based on qualitative interviews.
    Nguyen TA; Knight R; Mant A; Razee H; Brooks G; Dang TH; Roughead EE
    BMC Health Serv Res; 2018 Jul; 18(1):587. PubMed ID: 30055601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Governance in managing public health resources in Brazilian municipalities.
    Avelino G; Barberia LG; Biderman C
    Health Policy Plan; 2014 Sep; 29(6):694-702. PubMed ID: 23411119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The integration of the global HIV/AIDS response into universal health coverage: desirable, perhaps possible, but far from easy.
    Ooms G; Kruja K
    Global Health; 2019 Jun; 15(1):41. PubMed ID: 31215446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugs and development: the global impact of drug use and trafficking on social and economic development.
    Singer M
    Int J Drug Policy; 2008 Dec; 19(6):467-78. PubMed ID: 19038724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Corruption in health systems.
    Nishtar S
    Lancet; 2010 Sep; 376(9744):874. PubMed ID: 20833301
    [No Abstract]   [Full Text] [Related]  

  • 53. Corruption: An Impediment to Delivering Pathology and Laboratory Services in Resource-Limited Settings.
    Glynn EH; Amukele T; Vian T
    Am J Clin Pathol; 2021 Nov; 156(6):958-968. PubMed ID: 34219146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corruption in healthcare and medicine: why should physicians and bioethicists care and what should they do?
    Chattopadhyay S
    Indian J Med Ethics; 2013; 10(3):153-9. PubMed ID: 23912727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. From blockchain technology to global health equity: can cryptocurrencies finance universal health coverage?
    Till BM; Peters AW; Afshar S; Meara JG; Meara J
    BMJ Glob Health; 2017; 2(4):e000570. PubMed ID: 29177101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dying of corruption.
    Holmberg S; Rothstein B
    Health Econ Policy Law; 2011 Oct; 6(4):529-47. PubMed ID: 20809992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding medical corruption in China: a mixed-methods study.
    Fu H; Lai Y; Li Y; Zhu Y; Yip W
    Health Policy Plan; 2023 Apr; 38(4):496-508. PubMed ID: 36798965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "It Keeps Us from Putting Drugs in Pockets": How a Public-Private Partnership for Hospital Management May Help Curb Corruption.
    Vian T; Mcintosh N; Grabowski A
    Perm J; 2017; 21():16-113. PubMed ID: 28746025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Our Blind Spots in the Fight Against Health Systems Corruption Comment on "We Need to Talk About Corruption in Health Systems".
    Huss R
    Int J Health Policy Manag; 2020 Jan; 9(1):34-38. PubMed ID: 31902193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The disease of corruption: views on how to fight corruption to advance 21
    Mackey TK; Kohler JC; Savedoff WD; Vogl F; Lewis M; Sale J; Michaud J; Vian T
    BMC Med; 2016 Sep; 14(1):149. PubMed ID: 27680102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.